Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Patients taking selegeline may have received more levodopa than necessary.
Olanow
C W
CW
Godbold
J H
JH
Koller
W
W
D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000009:adverse effects*; D004311:Double-Blind Method; D007980:Levodopa / Q000008:administration & dosage / Q000009:adverse effects*; D010300:Parkinson Disease / Q000188:drug therapy / Q000401:mortality*; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D012642:Selegiline / Q000008:administration & dosage / Q000009:adverse effects*
D000978:Antiparkinson Agents; D012642:Selegiline; D007980:Levodopa